Stimufend
NorthStar has partnered with Fresenius Kabi to exclusively commercialize Stimufend in the U.S. under the Aisling label.
Stimufend is a biosimilar to Neulasta® (pegfilgrastim) approved by the FDA. It is used to decrease the incidence of infection, as manifested by febrile neutropenia, in patients with non‑myeloid malignancies receiving myelosuppressive chemotherapy.
Indications & usage
Stimufend is indicated to:
- Decrease the incidence of infection, as manifested by febrile neutropenia, in patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs associated with a clinically significant incidence of febrile neutropenia
- Increase survival in patients acutely exposed to myelosuppressive doses of radiation (Hematopoietic Subsyndrome of Acute Radiation Syndrome)
Limitations of Use: Stimufend is not indicated for the mobilization of peripheral blood progenitor cells for hematopoietic stem cell transplantation.
Dosing & administration
Stimufend (pegfilgrastim-fpgk) syringe is designed for ease of use and safe delivery.
Convenient dosing, administration, and storage of Stimufend
- Provides the convenience of only 1 injection per chemotherapy cycle
- Do not administer Stimufend between 14 days before and 24 hours after administration of cytotoxic chemotherapy
- 6 mg/0.6 mL solution for subcutaneous injection via a single-dose, pre-filled syringe
- Can be stored at room temperature, 68°F to 77°F (20°C to 25°C), for up to 72 hours*
- Long shelf life of 36 months
Note: Stimufend must be refrigerated. Stimufend that is left at room temperature for more than 72 hours must be discarded.
Features of the Stimufend pre-filled syringe
- Pre-filled syringe with a 27-gauge needle
- Fully passive safety device
- Automatic activation needle guard
- Designed for home and clinical use
Note: The needle cap contains dry natural rubber (derived from latex).
Safety information
Patient support programs
Copay assistance program for Stimufend
KabiCare™ provides additional support programs to eligible* patients. If you have commercial or private insurance, you may be eligible* for the copay assistance program that lowers your out-of-pocket costs to as little as $0/month for Stimufend, with an annual maximum.
*Eligibility criteria apply. Patients are not eligible for commercial copay assistance if the prescription is eligible to be reimbursed, in whole or in part, by any state or federal healthcare program